M. D. Weitzman, S. R. Kyöstiö, R. M. Kotin, and R. A. Owens, Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA., Proc. Natl. Acad. Sci. USA 91, pp.5808-5812, 1994.
DOI : 10.1073/pnas.91.13.5808

P. L. Hermonat and N. Muzyczka, Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells., Proc. Natl. Acad. Sci. USA 81, pp.6466-6470, 1984.
DOI : 10.1073/pnas.81.20.6466

G. Gao, L. Zhong, D. , and O. , Exploiting Natural Diversity of AAV for the Design of Vectors with Novel Properties, Methods Mol. Biol, vol.807, pp.93-118, 2011.
DOI : 10.1007/978-1-61779-370-7_4

J. E. Rabinowitz, F. Rolling, C. Li, H. Conrath, W. Xiao et al., Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity, Journal of Virology, vol.76, issue.2, pp.791-801, 2002.
DOI : 10.1128/JVI.76.2.791-801.2002

Q. Wang, Z. Wu, J. Zhang, J. Firrman, H. Wei et al., A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors, Molecular Therapy - Methods & Clinical Development, vol.7, pp.146-156, 2017.
DOI : 10.1016/j.omtm.2017.11.002

B. Dong, A. R. Moore, J. Dai, S. Roberts, K. Chu et al., A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy, Nucleic Acids Research, vol.22, issue.13, pp.6609-6617, 2013.
DOI : 10.1089/hum.2010.202

A. Backovic, T. Cervelli, A. Salvetti, L. Zentilin, M. Giacca et al., Capsid protein expression and adeno-associated virus like particles assembly in Saccharomyces cerevisiae, Microbial Cell Factories, vol.11, issue.1, 2012.
DOI : 10.1006/bbrc.1999.1831

S. S. Thakur, Production of recombinant adeno-associated viral vectors in yeast, 2012.

D. Barajas, J. J. Aponte-ubillus, H. Akeefe, T. Cinek, J. Peltier et al., Generation of infectious recombinant Adeno-associated virus in Saccharomyces cerevisiae, PLOS ONE, vol.100, issue.26, 2017.
DOI : 10.1371/journal.pone.0173010.s002

M. Urabe, C. Ding, and R. M. Kotin, Insect Cells as a Factory to Produce Adeno-Associated Virus Type 2 Vectors, Human Gene Therapy, vol.13, issue.16, pp.1935-1943, 2002.
DOI : 10.1089/10430340260355347

D. Grimm, A. Kern, K. Rittner, and J. A. Kleinschmidt, Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors, Human Gene Therapy, vol.9, issue.18, pp.2745-2760, 1998.
DOI : 10.1089/hum.1998.9.18-2745

M. Schnödt, M. Schmeer, B. Kracher, C. Krüsemann, L. E. Espinosa et al., DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations, Molecular Therapy - Nucleic Acids, vol.5, p.355, 2016.
DOI : 10.1038/mtna.2016.60

J. C. Grieger, S. M. Soltys, and R. J. Samulski, Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector, Molecular Therapy, vol.24, issue.2, pp.287-297, 2016.
DOI : 10.1038/mt.2015.187

R. M. Kotin and R. O. Snyder, Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines, Human Gene Therapy, vol.28, issue.4, pp.350-360, 2017.
DOI : 10.1089/hum.2017.042

T. Virag, S. Cecchini, and R. M. Kotin, Producing Recombinant Adeno-Associated Virus in Foster Cells: Overcoming Production Limitations Using a Baculovirus???Insect Cell Expression Strategy, Human Gene Therapy, vol.20, issue.8, pp.807-817, 2009.
DOI : 10.1089/hum.2009.092

L. Galibert and O. Merten, Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases, Journal of Invertebrate Pathology, vol.107, pp.80-93, 2011.
DOI : 10.1016/j.jip.2011.05.008

R. H. Smith, J. R. Levy, and R. M. Kotin, A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells, Molecular Therapy, vol.17, issue.11, pp.1888-1896, 2009.
DOI : 10.1038/mt.2009.128

J. L. Vaughn, R. H. Goodwin, G. J. Tompkins, and P. Mccawley, The establishment of two cell lines from the insectspodoptera frugiperda (lepidoptera; noctuidae), In Vitro, vol.25, issue.4, pp.213-217, 1977.
DOI : 10.1016/B978-0-12-429740-1.50037-0

M. G. Aucoin, J. A. Mena, and A. A. Kamen, Bioprocessing of Baculovirus Vectors: A Review, Current Gene Therapy, vol.10, issue.3, pp.174-186, 2010.
DOI : 10.2174/156652310791321288

M. Mietzsch, H. Hering, E. Hammer, M. Agbandje-mckenna, S. Zolotukhin et al., 9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA, Human Gene Therapy Methods, vol.28, issue.1, pp.15-22, 2017.
DOI : 10.1089/hgtb.2016.164

M. Mietzsch, S. Grasse, C. Zurawski, S. Weger, A. Bennett et al., OneBac: Platform for Scalable and High-Titer Production of Adeno-Associated Virus Serotype 1???12 Vectors for Gene Therapy, Human Gene Therapy, vol.25, issue.3, pp.212-222, 2014.
DOI : 10.1089/hum.2013.184

L. Adamson-small, M. Potter, B. J. Byrne, C. , and N. , Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System, Human Gene Therapy Methods, vol.28, issue.1, pp.1-14, 2017.
DOI : 10.1089/hgtb.2016.151

D. L. Thomas, L. Wang, J. Niamke, J. Liu, W. Kang et al., Scalable Recombinant Adeno-Associated Virus Production Using Recombinant Herpes Simplex Virus Type 1 Coinfection of Suspension-Adapted Mammalian Cells, Human Gene Therapy, vol.20, issue.8, pp.861-870, 2009.
DOI : 10.1089/hum.2009.004

L. Adamson-small, M. Potter, D. J. Falk, B. Cleaver, B. J. Byrne et al., A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform, Molecular Therapy - Methods & Clinical Development, vol.3, p.16031, 2016.
DOI : 10.1038/mtm.2016.31

J. D. Chulay, G. Ye, D. L. Thomas, D. R. Knop, J. M. Benson et al., Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production Method, Human Gene Therapy, vol.22, issue.2, pp.155-165, 2011.
DOI : 10.1089/hum.2010.118

K. R. Clark, F. Voulgaropoulou, D. M. Fraley, J. , and P. R. , Cell Lines for the Production of Recombinant Adeno-Associated Virus, Human Gene Therapy, vol.6, issue.10, pp.1329-1341, 1995.
DOI : 10.1089/hum.1995.6.10-1329

G. P. Gao, G. Qu, L. Z. Faust, R. K. Engdahl, W. Xiao et al., High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle Virus, Human Gene Therapy, vol.9, issue.16, pp.2353-2362, 1998.
DOI : 10.1089/hum.1998.9.16-2353

G. Chadeuf, D. Favre, J. Tessier, N. Provost, P. Nony et al., Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome, The Journal of Gene Medicine, vol.49, issue.4, pp.260-268, 2000.
DOI : 10.1128/MCB.14.2.1333

L. C. Mathews, J. T. Gray, M. R. Gallagher, and R. O. Snyder, [23] Recombinant adeno-associated viral vector production using stable packaging and producer cell lines, Methods Enzymol, vol.346, pp.393-413, 2002.
DOI : 10.1016/S0076-6879(02)46068-5

D. Farson, T. C. Harding, L. Tao, J. Liu, S. Powell et al., Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors, The Journal of Gene Medicine, vol.6, issue.12, pp.1369-1381, 2004.
DOI : 10.1002/jgm.622

J. Tessier, G. Chadeuf, P. Nony, H. Avet-loiseau, P. Moullier et al., Characterization of Adenovirus-Induced Inverted Terminal Repeat-Independent Amplification of Integrated Adeno-Associated Virus rep-cap Sequences, Journal of Virology, vol.75, issue.1, pp.375-383, 2001.
DOI : 10.1128/JVI.75.1.375-383.2001

G. P. Gao, F. Lu, J. C. Sanmiguel, P. T. Tran, Z. Abbas et al., Rep/Cap Gene Amplification and High-Yield Production of AAV in an A549 Cell Line Expressing Rep/Cap, Molecular Therapy, vol.5, issue.5, pp.644-649, 2002.
DOI : 10.1006/mthe.2001.0591

P. Nony, J. Tessier, G. Chadeuf, P. Ward, A. Giraud et al., Novel cis-Acting Replication Element in the Adeno-Associated Virus Type 2 Genome Is Involved in Amplification of Integrated rep-cap Sequences, Journal of Virology, vol.75, issue.20, pp.9991-9994, 2001.
DOI : 10.1128/JVI.75.20.9991-9994.2001

A. François, M. Guilbaud, R. Awedikian, G. Chadeuf, P. Moullier et al., The Cellular TATA Binding Protein Is Required for Rep-Dependent Replication of a Minimal Adeno-Associated Virus Type 2 p5 Element, Journal of Virology, vol.79, issue.17, pp.11082-11094, 2005.
DOI : 10.1128/JVI.79.17.11082-11094.2005

K. R. Clark, F. Voulgaropoulou, J. , and P. R. , A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adenoassociated virus vectors, Gene Ther, vol.3, pp.1124-1132, 1996.

E. Toublanc, A. Benraiss, D. Bonnin, V. Blouin, N. Brument et al., Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2(rAAV2) particle assembly using stable producer cell lines, The Journal of Gene Medicine, vol.6, issue.5, pp.555-564, 2004.
DOI : 10.1002/jgm.542
URL : https://hal.archives-ouvertes.fr/hal-00144060

Q. Yang, F. Chen, and J. P. Trempe, Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins, J. Virol, vol.68, pp.4847-4856, 1994.

P. Saudan, J. Vlach, and P. Beard, Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb, The EMBO Journal, vol.19, issue.16, pp.4351-4361, 2000.
DOI : 10.1093/emboj/19.16.4351

Z. Li, J. R. Brister, D. Im, and N. Muzyczka, Characterization of the adenoassociated virus Rep protein complex formed on the viral origin of DNA replication, Virology, vol.313, issue.2, pp.364-376, 2003.
DOI : 10.1016/S0042-6822(03)00340-4

C. Berthet, K. Raj, P. Saudan, and P. Beard, How adeno-associated virus Rep78 protein arrests cells completely in S phase, Proc. Natl. Acad. Sci. USA, pp.13634-13639, 2005.
DOI : 10.1074/jbc.M205911200

M. Schmidt, S. Afione, and R. M. Kotin, Adeno-associated virus type 2, 2000.

L. S. Chang, Y. Shi, and T. Shenk, Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor, J. Virol, vol.63, pp.3479-3488, 1989.

C. Qiao, B. Wang, X. Zhu, J. Li, X. et al., A Novel Gene Expression Control System and Its Use in Stable, High-Titer 293 Cell-Based Adeno-Associated Virus Packaging Cell Lines, Journal of Virology, vol.76, issue.24, pp.13015-13027, 2002.
DOI : 10.1128/JVI.76.24.13015-13027.2002

H. Mizukami, T. Okada, Y. Ogasawara, T. Matsushita, M. Urabe et al., Separate Control of Rep and Cap Expression Using Mutant and Wild-Type LoxP Sequences and Improved Packaging System for Adeno-Associated Virus Vector Production, Molecular Biotechnology, vol.27, issue.1, pp.7-14, 2004.
DOI : 10.1385/MB:27:1:07

Z. Yuan, C. Qiao, P. Hu, J. Li, X. et al., A Versatile Adeno-Associated Virus Vector Producer Cell Line Method for Scalable Vector Production of Different Serotypes, Human Gene Therapy, vol.22, issue.5, pp.613-624, 2011.
DOI : 10.1089/hum.2010.241

K. R. Clark, X. Liu, J. P. Mcgrath, J. , and P. R. , Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses, Human Gene Therapy, vol.10, issue.6, pp.1031-1039, 1999.
DOI : 10.1089/10430349950018427

N. Brument, R. Morenweiser, V. Blouin, E. Toublanc, I. Raimbaud et al., A Versatile and Scalable Two-Step Ion-Exchange Chromatography Process for the Purification of Recombinant Adeno-associated Virus Serotypes-2 and -5, Molecular Therapy, vol.6, issue.5, pp.678-686, 2002.
DOI : 10.1016/S1525-0016(02)90719-7
URL : https://hal.archives-ouvertes.fr/hal-00128279

T. Flotte, B. Carter, C. Conrad, W. Guggino, T. Reynolds et al., A Phase I Study of an Adeno-Associated Virus-CFTR Gene Vector in Adult CF Patients with Mild Lung Disease. Johns Hopkins Children's Center, Baltimore, Maryland, Human Gene Therapy, vol.7, issue.9, pp.1145-1159, 1996.
DOI : 10.1089/hum.1996.7.9-1145

B. A. Thorne, R. K. Takeya, and R. W. Peluso, Manufacturing Recombinant Adeno-Associated Viral Vectors from Producer Cell Clones, Human Gene Therapy, vol.20, issue.7, pp.707-714, 2009.
DOI : 10.1089/hum.2009.070

J. Martin, A. Frederick, Y. Luo, R. Jackson, M. Joubert et al., Generation and Characterization of Adeno-Associated Virus Producer Cell Lines for Research and Preclinical Vector Production, Human Gene Therapy Methods, vol.24, issue.4, pp.253-269, 2013.
DOI : 10.1089/hgtb.2013.046

V. Blouin, N. Brument, E. Toublanc, I. Raimbaud, P. Moullier et al., Improving rAAV production and purification: towards the definition of a scaleable process, The Journal of Gene Medicine, vol.6, issue.S1, pp.223-228, 2004.
DOI : 10.1002/jgm.505

J. F. Wright, Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment, Biomedicines, vol.11, issue.4, pp.80-97, 2014.
DOI : 10.1016/j.ymthe.2004.08.030

J. F. Wright and O. Zelenaia, Vector Characterization Methods for Quality Control Testing of Recombinant Adeno-Associated Viruses, Methods Mol. Biol, vol.737, pp.247-278, 2011.
DOI : 10.1007/978-1-61779-095-9_11

T. R. Flotte, X. Barraza-ortiz, R. Solow, S. A. Afione, B. J. Carter et al., An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction, Gene Ther, vol.2, pp.29-37, 1995.

C. L. Halbert, J. M. Allen, and A. D. Miller, Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 Vectors, Journal of Virology, vol.75, issue.14, pp.6615-6624, 2001.
DOI : 10.1128/JVI.75.14.6615-6624.2001

C. L. Halbert, M. J. Metzger, S. L. Lam, and A. D. Miller, Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production, Gene Therapy, vol.71, issue.4, pp.411-417, 2011.
DOI : 10.1016/0378-1119(85)90170-2

E. Lecomte, B. Tournaire, B. Cogné, J. Dupont, P. Lindenbaum et al., Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing, Molecular Therapy - Nucleic Acids, vol.4, p.260, 2015.
DOI : 10.1038/mtna.2015.32

B. Hauck, S. L. Murphy, P. H. Smith, G. Qu, X. Liu et al., Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune Responses, Molecular Therapy, vol.17, issue.1, pp.144-152, 2009.
DOI : 10.1038/mt.2008.227

J. A. Allay, S. Sleep, S. Long, D. M. Tillman, R. Clark et al., Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial, Human Gene Therapy, vol.22, issue.5, pp.595-604, 2011.
DOI : 10.1089/hum.2010.202

G. J. Ye, M. M. Scotti, J. Liu, L. Wang, D. R. Knop et al., Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system, Gene Therapy, vol.33, issue.2, pp.135-144, 2011.
DOI : 10.1073/pnas.55.6.1467

M. Penaud-budloo, E. Lecomte, A. Guy-duché, S. Saleun, A. Roulet et al., Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells, Human Gene Therapy Methods, vol.28, issue.3, pp.148-162, 2017.
DOI : 10.1089/hgtb.2016.185
URL : https://hal.archives-ouvertes.fr/hal-01608396

G. Chadeuf, C. Ciron, P. Moullier, and A. Salvetti, Evidence for Encapsidation of Prokaryotic Sequences during Recombinant Adeno-Associated Virus Production and Their in Vivo Persistence after Vector Delivery, Molecular Therapy, vol.12, issue.4, pp.744-753, 2005.
DOI : 10.1016/j.ymthe.2005.06.003

B. Nambiar, C. Sookdeo, C. Berthelette, P. Jackson, R. Piraino et al., Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection, Human Gene Therapy Methods, vol.28, issue.1, pp.23-38, 2017.
DOI : 10.1089/hgtb.2016.124

G. Ye, E. Budzynski, P. Sonnentag, P. E. Miller, A. K. Sharma et al., Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, Human Gene Therapy Clinical Development, vol.26, issue.3, pp.165-176, 2015.
DOI : 10.1089/humc.2015.076

G. J. Ye, E. Budzynski, P. Sonnentag, T. M. Nork, P. E. Miller et al., Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia, Human Gene Therapy Clinical Development, vol.27, issue.1, pp.27-36, 2016.
DOI : 10.1089/humc.2015.163

G. J. Ye, E. Budzynski, P. Sonnentag, T. M. Nork, P. E. Miller et al., Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia, Human Gene Therapy Clinical Development, vol.27, issue.1, pp.37-48, 2016.
DOI : 10.1089/humc.2015.164

G. Ye, T. Conlon, K. Erger, P. Sonnentag, A. K. Sharma et al., Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice, RS1-deficient mice. Hum, pp.177-184, 2015.
DOI : 10.1089/humc.2015.077

T. R. Flotte, B. C. Trapnell, M. Humphries, B. Carey, R. Calcedo et al., -Antitrypsin: Interim Results, Human Gene Therapy, vol.22, issue.10, pp.1239-1247, 2011.
DOI : 10.1089/hum.2011.053

P. H. Smith, F. J. Wright, G. Qu, S. Patarroyo-white, A. Parker et al., Packaging of host cell and plasmid DNA into recombinant adeno-associated virus particles produced by triple transfection, Mol. Ther, vol.7, p.348, 2003.

M. Brimble, J. Zhou, C. Morton, M. Meagher, A. C. Nathwani et al., 547. AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs, Molecular Therapy, vol.24, pp.24-218, 2016.
DOI : 10.1016/S1525-0016(16)33355-X

J. T. Gray and S. Zolotukhin, Design and Construction of Functional AAV Vectors, Methods Mol. Biol, vol.807, pp.25-46, 2011.
DOI : 10.1007/978-1-61779-370-7_2

B. Dong, X. Duan, H. Y. Chow, L. Chen, H. Lu et al., Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors, PLoS ONE, vol.10, issue.2, p.86453, 2014.
DOI : 10.1371/journal.pone.0086453.s002

B. Strobel, F. D. Miller, W. Rist, and T. Lamla, Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications, Human Gene Therapy Methods, vol.26, issue.4, pp.147-157, 2015.
DOI : 10.1089/hgtb.2015.051

S. Satkunanathan, J. Wheeler, R. Thorpe, and Y. Zhao, Establishment of a Novel Cell Line for the Enhanced Production of Recombinant Adeno-Associated Virus Vectors for Gene Therapy, Human Gene Therapy, vol.25, issue.11, pp.929-941, 2014.
DOI : 10.1089/hum.2014.041

J. Qiu and K. E. Brown, A 110-kDa Nuclear Shuttle Protein, Nucleolin, Specifically Binds to Adeno-Associated Virus Type 2 (AAV-2) Capsid, Virology, vol.257, issue.2, pp.373-382, 1999.
DOI : 10.1006/viro.1999.9664

J. S. Johnson and R. J. Samulski, Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus, Journal of Virology, vol.83, issue.6, pp.2632-2644, 2009.
DOI : 10.1128/JVI.02309-08

J. M. Bevington, P. G. Needham, K. C. Verrill, R. F. Collaco, V. Basrur et al., Adeno-associated virus interactions with B23/Nucleophosmin: Identification of sub-nucleolar virion regions, Virology, vol.357, issue.1, pp.102-113, 2007.
DOI : 10.1016/j.virol.2006.07.050

J. Denard, C. Jenny, V. Blouin, P. Moullier, and F. Svinartchouk, Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates, Molecular Therapy - Methods & Clinical Development, vol.1, p.14031, 2014.
DOI : 10.1038/mtm.2014.31

J. Denard, C. Beley, R. Kotin, R. Lai-kuen, S. Blot et al., Human Galectin 3 Binding Protein Interacts with Recombinant Adeno-Associated Virus Type 6, Journal of Virology, vol.86, issue.12, pp.6620-6631, 2012.
DOI : 10.1128/JVI.00297-12

D. A. Muruve, The Innate Immune Response to Adenovirus Vectors, Human Gene Therapy, vol.15, issue.12, 2004.
DOI : 10.1089/hum.2004.15.1157

B. A. Thorne, P. Quigley, G. Nichols, C. Moore, E. Pastor et al., Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process, Biologicals, vol.36, issue.1, pp.7-18, 2008.
DOI : 10.1016/j.biologicals.2007.04.001

W. Kang, L. Wang, H. Harrell, J. Liu, D. L. Thomas et al., An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes, Gene Therapy, vol.3, issue.2, pp.229-239, 2009.
DOI : 10.1038/sj.gt.3300938

N. D. Van-loo, E. Fortunati, E. Ehlert, M. Rabelink, F. Grosveld et al., Baculovirus Infection of Nondividing Mammalian Cells: Mechanisms of Entry and Nuclear Transport of Capsids, Journal of Virology, vol.75, issue.2, pp.961-970, 2001.
DOI : 10.1128/JVI.75.2.961-970.2001

T. A. Kost, C. , and J. P. , Recombinant baculoviruses as mammalian cell gene-delivery vectors, Trends in Biotechnology, vol.20, issue.4, pp.173-180, 2002.
DOI : 10.1016/S0167-7799(01)01911-4

J. P. Laakkonen, M. U. Kaikkonen, P. H. Ronkainen, T. O. Ihalainen, E. A. Niskanen et al., Baculovirus-mediated immediate-early gene expression and nuclear reorganization in human cells, Cellular Microbiology, vol.45, issue.11, pp.667-681, 2008.
DOI : 10.1006/viro.1994.1332

R. Fujita, T. Matsuyama, J. Yamagishi, K. Sahara, S. Asano et al., Expression of Autographa californica Multiple Nucleopolyhedrovirus Genes in Mammalian Cells and Upregulation of the Host ??-Actin Gene, Journal of Virology, vol.80, issue.5, pp.2390-2395, 2006.
DOI : 10.1128/JVI.80.5.2390-2395.2006

T. Abe and Y. Matsuura, Host Innate Immune Responses Induced by Baculovirus in Mammals, Current Gene Therapy, vol.10, issue.3, pp.226-231, 2010.
DOI : 10.2174/156652310791321279

I. Margine, L. Martinez-gil, Y. Y. Chou, and F. Krammer, Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity, PLoS ONE, vol.83, issue.12, 2012.
DOI : 10.1371/journal.pone.0051559.s001

P. Rueda, J. Fominaya, J. P. Langeveld, C. Bruschke, C. Vela et al., Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles, Vaccine, vol.19, issue.7-8, pp.726-734, 2000.
DOI : 10.1016/S0264-410X(00)00259-0

T. A. Grein, R. Michalsky, C. , and P. , Virus Separation Using Membranes, Methods Mol. Biol, vol.1104, pp.459-491, 2014.
DOI : 10.1007/978-1-62703-733-4_26

W. T. Hermens and J. P. Smith, Removal of contaminating viruses from AAV preparations. World Intellectual Property Organization Patent, pp.36118-36119, 2013.

S. T. Tjia, G. M. Zu-altenschildesche, and W. Doerfler, Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells, Virology, vol.125, pp.107-117, 1983.

S. A. Rice and D. M. Knipe, Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27, J. Virol, vol.64, pp.1704-1715, 1990.

D. R. Knop and H. Harrell, Bioreactor Production of Recombinant Herpes Simplex Virus Vectors, Biotechnology Progress, vol.19, issue.Part 2, pp.715-721, 2007.
DOI : 10.1021/bp060373p

G. J. Ye, M. M. Scotti, D. L. Thomas, L. Wang, D. R. Knop et al., Herpes Simplex Virus Clearance During Purification of a Recombinant Adeno-Associated Virus Serotype 1 Vector, Human Gene Therapy Clinical Development, vol.25, issue.4, pp.212-217, 2014.
DOI : 10.1089/humc.2014.060

C. Mueller, G. Gernoux, A. M. Gruntman, F. Borel, E. P. Reeves et al., 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency, Molecular Therapy, vol.25, issue.6, pp.1387-1394, 2017.
DOI : 10.1016/j.ymthe.2017.03.029

J. N. Leonard, P. Ferstl, A. Delgado, and D. V. Schaffer, Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus, Biotechnology and Bioengineering, vol.6, issue.5, pp.1170-1179, 2007.
DOI : 10.1016/S0167-4838(01)00348-X

I. H. Maxwell, F. Maxwell, and J. Schaack, An adenovirus type 5 mutant with the preterminal protein gene deleted efficiently provides helper functions for the production of recombinant adeno-associated virus, J. Virol, vol.72, pp.8371-8373, 1998.

C. Jenny, E. Toublanc, O. Danos, and O. W. Merten, Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells, Cytotechnology, vol.19, issue.Suppl 1, pp.11-23, 2005.
DOI : 10.1099/0022-1317-80-9-2477

D. Grimm, A. Kern, M. Pawlita, F. Ferrari, R. Samulski et al., Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2, Gene Therapy, vol.6, issue.7, pp.1322-1330, 1999.
DOI : 10.1038/sj.gt.3300946

G. Qu, J. Bahr-davidson, J. Prado, A. Tai, F. Cataniag et al., Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography, Journal of Virological Methods, vol.140, issue.1-2, pp.183-192, 2007.
DOI : 10.1016/j.jviromet.2006.11.019

B. Burnham, S. Nass, E. Kong, M. Mattingly, D. Woodcock et al., Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors, Human Gene Therapy Methods, vol.26, issue.6, pp.228-242, 2015.
DOI : 10.1089/hgtb.2015.048

M. G. Aucoin, M. Perrier, and A. A. Kamen, Production of adeno-associated viral vectors in insect cells using triple infection: Optimization of baculovirus concentration ratios, Biotechnology and Bioengineering, vol.65, issue.6, pp.1081-1092, 2006.
DOI : 10.1107/S0108768105018549

M. G. Aucoin, M. Perrier, and A. A. Kamen, Improving AAV vector yield in insect cells by modulating the temperature after infection, Biotechnology and Bioengineering, vol.73, issue.6, pp.1501-1509, 2007.
DOI : 10.1016/B978-0-12-429740-1.50041-2

L. H. Vandenberghe, R. Xiao, M. Lock, J. Lin, M. Korn et al., Efficient Serotype-Dependent Release of Functional Vector into the Culture Medium During Adeno-Associated Virus Manufacturing, Human Gene Therapy, vol.21, issue.10, pp.1251-1257, 2010.
DOI : 10.1089/hum.2010.107

D. Florencio, G. Precigout, G. Beley, C. Buclez, P. Garcia et al., Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors, Molecular Therapy - Methods & Clinical Development, vol.2, p.15024, 2015.
DOI : 10.1038/mtm.2015.24

E. Ayuso, F. Mingozzi, J. Montane, X. Leon, X. M. Anguela et al., High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency, Gene Therapy, vol.17, issue.4, pp.503-510, 2010.
DOI : 10.1182/blood-2007-03-080093

S. Zolotukhin, B. J. Byrne, E. Mason, I. Zolotukhin, M. Potter et al., Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Therapy, vol.70, issue.6, pp.973-985, 1999.
DOI : 10.1089/hum.1997.8.16-1911

A. Auricchio, M. Hildinger, E. O-'connor, G. P. Gao, W. et al., Isolation of Highly Infectious and Pure Adeno-Associated Virus Type 2 Vectors with a Single-Step Gravity-Flow Column, Human Gene Therapy, vol.12, issue.1, pp.71-76, 2001.
DOI : 10.1089/104303401450988

R. Anderson, I. Macdonald, T. Corbett, A. Whiteway, P. et al., A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction, Journal of Virological Methods, vol.85, issue.1-2, pp.23-34, 2000.
DOI : 10.1016/S0166-0934(99)00150-0

Q. Wang, M. Lock, A. J. Prongay, M. R. Alvira, B. Petkov et al., Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resin, Molecular Therapy - Methods & Clinical Development, vol.2, p.15040, 2015.
DOI : 10.1038/mtm.2015.40

S. Cecchini, T. Virag, and R. M. Kotin, Reproducible High Yields of Recombinant Adeno-Associated Virus Produced Using Invertebrate Cells in 0.02- to 200-Liter Cultures, Human Gene Therapy, vol.22, issue.8, pp.1021-1030, 2011.
DOI : 10.1089/hum.2010.250

P. S. Chahal, M. G. Aucoin, and A. Kamen, Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system, Journal of Virological Methods, vol.139, issue.1, pp.61-70, 2007.
DOI : 10.1016/j.jviromet.2006.09.011

R. H. Smith, L. Yang, and R. M. Kotin, Chromatography-Based Purification of Adeno-Associated Virus, Methods Mol. Biol, vol.434, pp.37-54, 2008.
DOI : 10.1007/978-1-60327-248-3_4

B. Venkatakrishnan, J. Yarbrough, J. Domsic, A. Bennett, B. Bothner et al., Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1-Unique N-Terminal Domain and Its Role in Capsid Trafficking, Journal of Virology, vol.87, issue.9, pp.4974-4984, 2013.
DOI : 10.1128/JVI.02524-12

M. Urabe, T. Nakakura, K. Xin, Y. Obara, H. Mizukami et al., Scalable Generation of High-Titer Recombinant Adeno-Associated Virus Type 5 in Insect Cells, Journal of Virology, vol.80, issue.4, pp.1874-1885, 2006.
DOI : 10.1128/JVI.80.4.1874-1885.2006

T. Okada, M. Nonaka-sarukawa, R. Uchibori, K. Kinoshita, H. Hayashita-kinoh et al., Scalable Purification of Adeno-associated Virus Serotype 1 (AAV1) and AAV8 Vectors, Using Dual Ion-Exchange Adsorptive Membranes, Human Gene Therapy, vol.20, issue.9, pp.1013-1021, 2009.
DOI : 10.1089/hum.2009.006

V. Rayaprolu, S. Kruse, R. Kant, B. Venkatakrishnan, N. Movahed et al., Comparative Analysis of Adeno-Associated Virus Capsid Stability and Dynamics, Journal of Virology, vol.87, issue.24, pp.13150-13160, 2013.
DOI : 10.1128/JVI.01415-13

S. Pacouret, M. Bouzelha, R. Shelke, E. Andres-mateos, R. Xiao et al., AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations, Molecular Therapy, vol.25, issue.6, pp.1375-1386, 2017.
DOI : 10.1016/j.ymthe.2017.04.001

A. Bennett, S. Patel, M. Mietzsch, A. Jose, B. Lins-austin et al., Thermal Stability as a Determinant of AAV Serotype Identity, Molecular Therapy - Methods & Clinical Development, vol.6, pp.171-182, 2017.
DOI : 10.1016/j.omtm.2017.07.003

A. M. Gruntman, L. Su, Q. Su, G. Gao, C. Mueller et al., Stability and Compatibility of Recombinant Adeno-Associated Virus Under Conditions Commonly Encountered in Human Gene Therapy Trials, Human Gene Therapy Methods, vol.26, issue.2, pp.71-76, 2015.
DOI : 10.1089/hgtb.2015.040

J. F. Wright, T. Le, J. Prado, J. Bahr-davidson, P. H. Smith et al., Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation, Molecular Therapy, vol.12, issue.1, pp.171-178, 2005.
DOI : 10.1016/j.ymthe.2005.02.021

A. E. Turnbull, A. Skulimowski, J. A. Smythe, A. , and I. E. , Adeno-Associated Virus Vectors Show Variable Dependence on Divalent Cations for Thermostability: Implications for Purification and Handling, Human Gene Therapy, vol.11, issue.4, pp.629-635, 2000.
DOI : 10.1089/10430340050015815

P. Guo, Y. El-gohary, K. Prasadan, C. Shiota, X. Xiao et al., Rapid and simplified purification of recombinant adeno-associated virus, Journal of Virological Methods, vol.183, issue.2, pp.139-146, 2012.
DOI : 10.1016/j.jviromet.2012.04.004

R. Xiao, E. Andres-mateos, T. Barungi, H. Qiu, and L. H. Vandenberghe, Downstream AAV recovery dramatically increased by non-ionic surfactant PF68, Mol. Ther, pp.25-329, 2017.

N. Louis, C. Evelegh, G. , and F. L. , Cloning and Sequencing of the Cellular???Viral Junctions from the Human Adenovirus Type 5 Transformed 293 Cell Line, Virology, vol.233, issue.2, pp.423-429, 1997.
DOI : 10.1006/viro.1997.8597

R. B. Dubridge, P. Tang, H. C. Hsia, P. M. Leong, J. H. Miller et al., Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system., Molecular and Cellular Biology, vol.7, issue.1, pp.379-387, 1987.
DOI : 10.1128/MCB.7.1.379

S. A. Corden, L. J. Sant-cassia, A. J. Easton, and A. G. Morris, The integration of HPV-18 DNA in cervical carcinoma, Molecular Pathology, vol.52, issue.5, pp.275-282, 1999.
DOI : 10.1136/mp.52.5.275

D. J. Giard, S. A. Aaronson, G. J. Todaro, P. Arnstein, J. H. Kersey et al., In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2, JNCI: Journal of the National Cancer Institute, vol.51, issue.5, pp.1417-1423, 1973.
DOI : 10.1093/jnci/51.5.1417

M. Stoker and I. Macpherson, Syrian Hamster Fibroblast Cell Line BHK21 and its Derivatives, Nature, vol.203, issue.4952, pp.1355-1357, 1964.
DOI : 10.1038/2031355a0

J. F. Wright, Manufacturing and characterizing AAV-based vectors for use in clinical studies, Gene Therapy, vol.4, issue.11, pp.840-848, 2008.
DOI : 10.1016/j.ymthe.2004.08.030

R. O. Snyder, M. Audit, F. , and J. D. , rAAV Vector Product Characterization and Stability Studies, Methods Mol. Biol, vol.807, pp.405-428, 2011.
DOI : 10.1007/978-1-61779-370-7_17

M. A. Robert, P. S. Chahal, A. Audy, A. Kamen, R. Gilbert et al., Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms, Biotechnology Journal, vol.86, issue.3, p.1600193, 2017.
DOI : 10.1128/JVI.01717-12